Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.

IMPORTANCE Prenatal folic acid supplements reduce the risk of neural tube defects in children, but it has not been determined whether they protect against other neurodevelopmental disorders. OBJECTIVE To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. DESIGN, SETTING, AND PATIENTS The study sample of 85,176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. MAIN OUTCOME MEASURE Specialist-confirmed diagnosis of ASDs. RESULTS At the end of follow-up, 270 children in the study sample had been diagnosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS. In children whose mothers took folic acid, 0.10% (64/61,042) had autistic disorder, compared with 0.21% (50/24,134) in those unexposed to folic acid. The adjusted OR for autistic disorder in children of folic acid users was 0.61 (95% CI, 0.41-0.90). No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use. CONCLUSIONS AND RELEVANCE Use of prenatal folic acid supplements around the time of conception was associated with a lower risk of autistic disorder in the MoBa cohort. Although these findings cannot establish causality, they do support prenatal folic acid supplementation.

[1]  J. Baio.  Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.

[2]  G. Baird,et al.  Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) , 2006, The Lancet.

[3]  Jan Alexander,et al.  Validity of a new food frequency questionnaire for pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). , 2007, Maternal & child nutrition.

[4]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[5]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .

[6]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[7]  G. Smith.  Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings? , 2008, Basic & clinical pharmacology & toxicology.

[8]  T.W.Sadler.  Langman's Medical Embryology , 1969 .

[9]  S. Wainwright.  Langmanʼs Medical Embryology. 11th Edition. , 2010 .

[10]  Linda C. Schmidt,et al.  Prenatal Vitamins, One-carbon Metabolism Gene Variants, and Risk for Autism , 2011, Epidemiology.

[11]  K J Rothman,et al.  Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. , 1989, JAMA.

[12]  A. Czeizel,et al.  Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation , 1992 .

[13]  Per Magnus,et al.  Self-selection and bias in a large prospective pregnancy cohort in Norway. , 2009, Paediatric and perinatal epidemiology.

[14]  Periconceptional folic acid exposure and risk of occurrent neural tube defects. , 1993 .

[15]  Jan Alexander,et al.  Methodological challenges when monitoring the diet of pregnant women in a large study: experiences from the Norwegian Mother and Child Cohort Study (MoBa). , 2007, Maternal & child nutrition.

[16]  Flora Tassone,et al.  Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. , 2012, The American journal of clinical nutrition.

[17]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[18]  Zachary Warren,et al.  A multisite study of the clinical diagnosis of different autism spectrum disorders. , 2012, Archives of general psychiatry.

[19]  Heidi Aase,et al.  Autism Spectrum Disorder, ADHD, Epilepsy, and Cerebral Palsy in Norwegian Children , 2012, Pediatrics.

[20]  P. Magnus,et al.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). , 2006, International journal of epidemiology.

[21]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[22]  G. Shaw,et al.  PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTS , 1995, Epidemiology.

[23]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[24]  Per Magnus,et al.  THE AUTISM BIRTH COHORT (ABC): A PARADIGM FOR GENE-ENVIRONMENT-TIMING RESEARCH , 2010, Molecular Psychiatry.

[25]  Z. Li,et al.  Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. , 2000, The New England journal of medicine.

[26]  D. Weir,et al.  Folate levels and neural tube defects. Implications for prevention. , 1995, JAMA.

[27]  T. Popović,et al.  CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. , 2010, MMWR. Morbidity and mortality weekly report.